192 related articles for article (PubMed ID: 15700248)
1. Cathlink 20: a subcutaneous implanted central venous access device used in children with sickle cell disease on long-term erythrocytapheresis--a report of low complication rates.
Raj A; Bertolone S; Bond S; Burnett D; Denker A
Pediatr Blood Cancer; 2005 Jun; 44(7):669-72. PubMed ID: 15700248
[TBL] [Abstract][Full Text] [Related]
2. Radiologic placement of a low profile implantable venous access port in a pediatric population.
Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
[TBL] [Abstract][Full Text] [Related]
3. Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
Titapiwatanakun R; Moir C; Pruthi RK; Stavlo PL; Schmidt KA; Rodriguez V
Haemophilia; 2009 Jan; 15(1):168-74. PubMed ID: 19149849
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports.
Carlo JT; Lamont JP; McCarty TM; Livingston S; Kuhn JA
Am J Surg; 2004 Dec; 188(6):722-7. PubMed ID: 15619490
[TBL] [Abstract][Full Text] [Related]
5. Use of subcutaneous implantable infusion systems in neoplastic and AIDS patients requiring long-term venous access.
Dionigi P; Cebrelli T; Jemos V; Minoli L; Gobbi P; Dimitrov G
Eur J Surg; 1995 Feb; 161(2):137-42. PubMed ID: 7772631
[TBL] [Abstract][Full Text] [Related]
6. Complications associated with an implantable vascular access device.
Dillon PA; Foglia RP
J Pediatr Surg; 2006 Sep; 41(9):1582-7. PubMed ID: 16952595
[TBL] [Abstract][Full Text] [Related]
7. Portacaths are safe for long-term regular blood transfusion in children with sickle cell anaemia.
Bartram JL; O'Driscoll S; Kulasekararaj AG; Height SE; Dick M; Patel S; Rees DC
Arch Dis Child; 2011 Nov; 96(11):1082-4. PubMed ID: 20605863
[TBL] [Abstract][Full Text] [Related]
8. Long-term central venous access in patients with sickle cell disease. Incidence of thrombotic and infectious complications.
Abdul-Rauf A; Gauderer M; Chiarucci K; Berman B
J Pediatr Hematol Oncol; 1995 Nov; 17(4):342-5. PubMed ID: 7583391
[TBL] [Abstract][Full Text] [Related]
9. Pinch-off syndrome in patients with sickle cell disease receiving erythrocytapheresis.
Nuss R; Cole L; Le T; Orsini E; Harned R
Pediatr Blood Cancer; 2008 Feb; 50(2):354-6. PubMed ID: 17091481
[TBL] [Abstract][Full Text] [Related]
10. Totally implantable central venous access devices in pediatric oncology--our experience in 46 patients.
De Backer A; Vanhulle A; Otten J; Deconinck P
Eur J Pediatr Surg; 1993 Apr; 3(2):101-6. PubMed ID: 8323914
[TBL] [Abstract][Full Text] [Related]
11. [Long-term experiences with central venous catheters in pediatric oncology].
Hadjilaskari P; Brühmüller S; Fengler R; Hartmann R; Waldschmidt J; Henze G
Monatsschr Kinderheilkd; 1990 Jan; 138(1):26-30. PubMed ID: 2107396
[TBL] [Abstract][Full Text] [Related]
12. [Application of long term subcutaneously implanted access into the central veins system of "PORT" type in the Clinic of Pediatry, Pediatric Hematology and Oncology in Zabrze--15 year own observations].
Bucki B; Tomaszewska R; Bubała H; Sońta-Jakimczyk D; Karpe J; Stoksik P
Wiad Lek; 2009; 62(2):93-8. PubMed ID: 20141056
[TBL] [Abstract][Full Text] [Related]
13. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.
Adler A; Yaniv I; Steinberg R; Solter E; Samra Z; Stein J; Levy I
J Hosp Infect; 2006 Mar; 62(3):358-65. PubMed ID: 16377030
[TBL] [Abstract][Full Text] [Related]
14. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
[TBL] [Abstract][Full Text] [Related]
15. The mechanisms of failure of totally implantable central venous access system: analysis of 73 cases with fracture of catheter.
Lin CH; Wu HS; Chan DC; Hsieh CB; Huang MH; Yu JC
Eur J Surg Oncol; 2010 Jan; 36(1):100-3. PubMed ID: 19709847
[TBL] [Abstract][Full Text] [Related]
16. Peripherally inserted central venous catheters are a good option for prolonged venous access in children with cancer.
Abedin S; Kapoor G
Pediatr Blood Cancer; 2008 Aug; 51(2):251-5. PubMed ID: 18421718
[TBL] [Abstract][Full Text] [Related]
17. [Experiences with a modified implantation technique of Port-A-Cath systems as continuous venous access in infants and children].
Erhard J; Lange R; Kremens B; Krause U; Eigler FW
Med Klin (Munich); 1991 Oct; 86(10):512-4. PubMed ID: 1758373
[TBL] [Abstract][Full Text] [Related]
18. [Subcutaneous chamber systems (ports) for long-term care in cancer patients].
Hájek R; Sevcík P; Ondrásek J; Mayer J; Vásová I; Král Z; Tomíska M; Krahulcová E; Penka M; Kubesová H
Vnitr Lek; 1995 Jan; 41(1):21-7. PubMed ID: 7716888
[TBL] [Abstract][Full Text] [Related]
19. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
Koonings PP; Given FT
J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727
[TBL] [Abstract][Full Text] [Related]
20. [Central venous indwelling catheter systems in pediatric oncology from the surgical viewpoint].
Petersen C; Fuchs J; Kotzur A; Strauss G
Klin Padiatr; 1998; 210(2):65-9. PubMed ID: 9561959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
